539 related articles for article (PubMed ID: 21945565)
1. Membrane-active host defense peptides--challenges and perspectives for the development of novel anticancer drugs.
Riedl S; Zweytick D; Lohner K
Chem Phys Lipids; 2011 Nov; 164(8):766-81. PubMed ID: 21945565
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial peptides with selective antitumor mechanisms: prospect for anticancer applications.
Deslouches B; Di YP
Oncotarget; 2017 Jul; 8(28):46635-46651. PubMed ID: 28422728
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial Peptides as Anticancer Agents: Functional Properties and Biological Activities.
Tornesello AL; Borrelli A; Buonaguro L; Buonaguro FM; Tornesello ML
Molecules; 2020 Jun; 25(12):. PubMed ID: 32575664
[TBL] [Abstract][Full Text] [Related]
4. Biomedical Relevance of Novel Anticancer Peptides in the Sensitive Treatment of Cancer.
Bakare OO; Gokul A; Wu R; Niekerk LA; Klein A; Keyster M
Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439786
[TBL] [Abstract][Full Text] [Related]
5. Learning from host-defense peptides: cationic, amphipathic peptoids with potent anticancer activity.
Huang W; Seo J; Willingham SB; Czyzewski AM; Gonzalgo ML; Weissman IL; Barron AE
PLoS One; 2014; 9(2):e90397. PubMed ID: 24587350
[TBL] [Abstract][Full Text] [Related]
6. Application Value of Antimicrobial Peptides in Gastrointestinal Tumors.
Liu Q; Wang L; He D; Wu Y; Liu X; Yang Y; Chen Z; Dong Z; Luo Y; Song Y
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069041
[TBL] [Abstract][Full Text] [Related]
7. Aggregation determines the selectivity of membrane-active anticancer and antimicrobial peptides: The case of killerFLIP.
Vaezi Z; Bortolotti A; Luca V; Perilli G; Mangoni ML; Khosravi-Far R; Bobone S; Stella L
Biochim Biophys Acta Biomembr; 2020 Feb; 1862(2):183107. PubMed ID: 31678022
[TBL] [Abstract][Full Text] [Related]
8. Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserine.
Riedl S; Leber R; Rinner B; Schaider H; Lohner K; Zweytick D
Biochim Biophys Acta; 2015 Nov; 1848(11 Pt A):2918-31. PubMed ID: 26239537
[TBL] [Abstract][Full Text] [Related]
9. Bacterial resistance mechanisms against host defense peptides.
Koprivnjak T; Peschel A
Cell Mol Life Sci; 2011 Jul; 68(13):2243-54. PubMed ID: 21560069
[TBL] [Abstract][Full Text] [Related]
10. [Host defense peptides and peptidomimetics as new weapons for cancer treatment].
Lapis K
Magy Onkol; 2010 Mar; 54(1):47-58. PubMed ID: 20350868
[TBL] [Abstract][Full Text] [Related]
11. New lytic peptides based on the D,L-amphipathic helix motif preferentially kill tumor cells compared to normal cells.
Papo N; Shai Y
Biochemistry; 2003 Aug; 42(31):9346-54. PubMed ID: 12899621
[TBL] [Abstract][Full Text] [Related]
12. Pro-apoptotic cationic host defense peptides rich in lysine or arginine to reverse drug resistance by disrupting tumor cell membrane.
Dai Y; Cai X; Shi W; Bi X; Su X; Pan M; Li H; Lin H; Huang W; Qian H
Amino Acids; 2017 Sep; 49(9):1601-1610. PubMed ID: 28664269
[TBL] [Abstract][Full Text] [Related]
13. [Cationic antimicrobial peptides: from innate immunity study to drug development. Up date].
Andrès E; Dimarcq JL
Med Mal Infect; 2007 Apr; 37(4):194-9. PubMed ID: 17306486
[TBL] [Abstract][Full Text] [Related]
14. Potential therapeutic application of host defense peptides.
Zhang L; Falla TJ
Methods Mol Biol; 2010; 618():303-27. PubMed ID: 20094872
[TBL] [Abstract][Full Text] [Related]
15. Plant antimicrobial peptides as potential anticancer agents.
Guzmán-Rodríguez JJ; Ochoa-Zarzosa A; López-Gómez R; López-Meza JE
Biomed Res Int; 2015; 2015():735087. PubMed ID: 25815333
[TBL] [Abstract][Full Text] [Related]
16. Peptide-based cancer therapy: opportunity and challenge.
Wu D; Gao Y; Qi Y; Chen L; Ma Y; Li Y
Cancer Lett; 2014 Aug; 351(1):13-22. PubMed ID: 24836189
[TBL] [Abstract][Full Text] [Related]
17. Tumor cell membrane-targeting cationic antimicrobial peptides: novel insights into mechanisms of action and therapeutic prospects.
Baxter AA; Lay FT; Poon IKH; Kvansakul M; Hulett MD
Cell Mol Life Sci; 2017 Oct; 74(20):3809-3825. PubMed ID: 28770291
[TBL] [Abstract][Full Text] [Related]
18. Cationic amphiphilic peptides with cancer-selective toxicity.
Schweizer F
Eur J Pharmacol; 2009 Dec; 625(1-3):190-4. PubMed ID: 19835863
[TBL] [Abstract][Full Text] [Related]
19. Heterochiral β-Peptide Polymers Combating Multidrug-Resistant Cancers Effectively without Inducing Drug Resistance.
Shao N; Yuan L; Ma P; Zhou M; Xiao X; Cong Z; Wu Y; Xiao G; Fei J; Liu R
J Am Chem Soc; 2022 Apr; 144(16):7283-7294. PubMed ID: 35420800
[TBL] [Abstract][Full Text] [Related]
20. Peptide motifs for cell-surface intervention: application to anti-infective and biopharmaceutical development.
Monk BC; Harding DR
BioDrugs; 2005; 19(4):261-78. PubMed ID: 16128608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
